- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gland Pharma received USFDA approval for Zoledronic Acid Injection, for Hypercalcemia of Malignancy and bone metastases. This product has estimated US annual sales of approximately ₹55.61 Cr, indicating a new market opportunity.